光动力治疗是一种非侵蚀性并具有一定靶向性的肿瘤治疗新方法.光动力治疗需要光敏剂、光和氧结合产生光动力反应.光敏剂是光动力治疗的关键和物质基础.本文概括介绍了已上市的和已被批准进入临床试验中的光敏剂,并根据其分子的骨架结构,将其分为分卟啉类、二氢卟吩(叶绿素)类和菌绿素/酞菁三类.同时从理想光敏剂应具备特点出发,探讨了研究中的光敏剂和光动力治疗的发展前景.
参考文献
[1] | Dougherty T J.Photodynamic Therapy(PDT) of Malignant Tumors[J].Crit Rev Oncol Hematol,1984,2:83-116. |
[2] | Brown S.Photodynamic Therapy:Two Photons are Better than One[J].Nat Photon,2008,2:394-395. |
[3] | Idris N M,Gnanasammandhan M K,Zhang J,et al.In vivo Photodynamic Therapy Using Upconversion Nanoparticles as Remote-controlled Nanotransducers[J].Nat Med,2012,18:1580-1585. |
[4] | Brasseur N,Ali H,Autenrieth D,et al.Biological Activities of Phthalocyanines-Ⅲ.Photoinactivation of V-79 Chinese Hamster Cells by Tetrasulfophthalocyanines[J].Photochem Photobiol,1985,42:515-521. |
[5] | Jia X,Yang F F,Li J,et al.Synthesis and in Vitro Photodynamic Activity of Oligomeric Ethylene Glycol-Quinoline Substituted Zinc(Ⅱ) Phthalocyanine Derivatives[J].J Med Chem,2013,56:5797-5805. |
[6] | Dennis E J,Dolmans G J,Dai F,et al.Photodynamic Therapy for Cancer[J].Nat Rev Cancer,2003,3(3):380-387. |
[7] | Charles J G.Photodynamic Therapy-methods and Protocols[M].New York:Humana Press,2010:26-28. |
[8] | Allison R R,Downie G H,Cuenca R,et al.Photosensitizers in Clinical PDT[J].Photodiagnosis Photodyn Ther,2004,1:27-42. |
[9] | Mroz P,Yaroslavsky A,Kharkwal G B,et al.Cell Death Pathways in Photodynamic Therapy of Cancer[J].Cancers,2011,3:2516-2539. |
[10] | Oleinick N L,Morris R L,Belichenko I.The Role of Apoptosis in Response to Photodynamic Therapy:What,Where,Why,and How[J].Photochem Photobiol Sci,2002,1:1-21. |
[11] | Igney F H,Krammer P H.Death and Anti-death:Tumour Resistance to Apoptosis[J].Nat Rev Cancer,2002,2:277-288. |
[12] | Boyle R W,Dolphin D.Structure and Biodistribution Relationships of Photodynamic Sensitizers[J].Photochem Photobiol,1996,64:469-485. |
[13] | Hamblin M R,Newman E L.On the Mechanism of the Tumour-localising Effect in Photodynamic Therapy[J].J Photochem Photobiol B,1994,23:3-8. |
[14] | Jori G,Reddi E.The Role of Lipoproteins in the Delivery of Tumour-targeting Photosensitizers[J].Int J Biochem,1993,25:1369-1375. |
[15] | Castano A P,Demidova T N,Hamblin M R.Mechanisms in Photodynamic Therapy:Part Three.Photosensitizer Pharmacokinetics,Biodistribution,Tumor Localization and Modes of Tumor Destruction[J].Photodiagnosis Photodyn Ther,2005,2:91-106. |
[16] | Castano A P,Demidova T N,Hamblin M R.Mechanisms in Photodynamic Therapy:Part Two.Cellular Signaling,Cell Metabolism and Modes of Cell Death[J].Photodiagnosis Photodyn Ther,2005,2:1-23. |
[17] | Juarranz A,Jaen P,Sanz-Rodriguez F,et al.Photodynamic Therapy of Cancer.Basic Principles and Applications[J].Clin Transl Oncol,2008,10 (3):148-154. |
[18] | Ron R A,Claudio H S.Oncologic Photodynamic Therapy Photosensitizers:A Clinical Review[J].Photodiagnosis Photodyn Ther,2010,7:61-75. |
[19] | Ron R A,Gordon H D,Rosa Cuenca,et al.Photosensitizers in Clinical PDT[J].Photodiagnosis Photodyn Ther,2004,1:27-42. |
[20] | Huang Z.An Update on the Regulatory Status of PDT Photosensitizers in China[J].Photodiagnosis Photodyn Ther,2008,5:285-287. |
[21] | Allison R R,Sibata C H.Photodiagnosis for Cutaneous Malignancy:A Brief Clinical and Technical Review[J].Photodiagnosis Photodyn Ther,2008,5:247-250. |
[22] | Michael R D,Scott L G,Stephen J W.Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy[J].J Med Chem,2004,47(16):3897-3915. |
[23] | LI Xufei,XUE Jinping,CHEN Naisheng,et al.Photo-generating Singlet Oxygen Ability of Metallophthalocyanines Substituted with Aromaticoxy Group Containing Nitrogen[J].Chinese J Appl Chem,2007,24 (9):1041-1044 (in Chinese).李旭飞,薛金萍,陈耐生,等.含氮芳氧基取代酞菁金属配合物光敏产生1O2的研究[J].应用化学,2007,24(9):1041-1044. |
[24] | Xue J P,Cai L X,Chen N S,et al.Synthesis and Photophysical Properties of Zinc Phthalocyanines Substituted with Quinolinoxy Group[J].J Porphyrins Phthalocyanines,2009,13:1206-1213. |
[25] | Nagao Kobayashi,Hiroshi Ogata,Naokazu Nonaka,et al.Effect of Peripheral Substitution on the Electronic Absorption and Fluorescence Spectra of Metal-Free and Zinc Phthalocyanines[J].Chem Eur J,2003,9:5123-5134. |
[26] | HUANG Jingling,HUANG Jiandong,LIU Ersheng,et al.Some Relationships Between Structures and Photodynamic Anti-cancer Activities of Phthalocyanines[J].Acta Phys-Chim Sin,2001,17(7):662-671 (in Chinese).黄金陵,黄剑东,刘尔生,等.酞菁配合物的结构与其光动力抗癌活性[J].物理化学学报,2001,17 (7):662-671. |
[27] | Tebello Nyokong.Effects of Substituents on the Photochemical and Photophysical Properties of Main Group Metal Phthalocyanines[J].Coord Chem Rev,2007,251:1707-1722. |
[28] | Ishii K,Kobayashi N.In:Kadish K M,Smith K M,Guilard E,Eds.The Porphyrin Handbook[M].Chapter 1,vol.16,Elsevier,2003 (chapter 1). |
[29] | Raymond Bonnett.Chemical Aspects of Photodynamic Therapy[M].Gordon and Breach Science Pulishers,(Australia Canada France Germany India Japan Luxembourg Malaysia The Netherlands Russia Singapore Switzerland),2000,1:144. |
[30] | Mang T S.Lasers and Light Sources for PDT:Past,Present and Future[J].Photodiagnosis Photodyn Ther,2004,1:43-48. |
[31] | Allison R R.Future PDT[J].Photodiagnosis Photodyn Ther,2009,6:231-234. |
[32] | Allison R R,Bagnato V S,Sibata C H.Future of Oncologic Photodynamic Therapy[J].Future Oncol,2010,6:929-940. |
[33] | Ron R A,Keyvan M.Photodynamic Therapy(PDT):PDT Mechanism[J].Clin Endosc,2013,46:24-29. |
[34] | Nawal S,Hubert van den B,Norbert L.Like a Bolt from the Blue:Phthalocyanines in Biomedical Optics[J].Molecules,2012,17:98-144. |
[35] | Chen B,Roskams T,de Witte P A.Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy[J].Photochem Photobiol,2002,76:509-513. |
上一张
下一张
上一张
下一张
计量
- 下载量()
- 访问量()
文章评分
- 您的评分:
-
10%
-
20%
-
30%
-
40%
-
50%